Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

UPEXI ($UPXI) Releases Q3 2026 Earnings

None

UPEXI ($UPXI) posted quarterly earnings results for Q3 2026 on Tuesday, May 12th. The company reported earnings of -$0.26 per share, missing estimates of -$0.20 by $0.06. The company also reported revenue of $4,560,000, missing estimates of $8,246,190 by $-3,686,190.

Stock price change since market close: -2.18%

You can see Quiver Quantitative's $UPXI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive UPXI Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

UPEXI Insider Trading Activity

UPXI Insider Trades

UPEXI insiders have traded $UPXI stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $UPXI stock by insiders over the last 6 months:

  • GENE SALKIND has made 3 purchases buying 250,000 shares for an estimated $673,500 and 0 sales.
  • ALLAN MARSHALL (Chief Executive Officer) has made 3 purchases buying 200,000 shares for an estimated $400,500 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

UPEXI Hedge Fund Activity

We have seen 43 institutional investors add shares of UPEXI stock to their portfolio, and 40 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

UPEXI Analyst Ratings

Wall Street analysts have issued reports on $UPXI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Cantor Fitzgerald issued a "Overweight" rating on 11/14/2025

To track analyst ratings and price targets for UPEXI, check out Quiver Quantitative's $UPXI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles